Hypoxic pulmonary vasoconstriction (HPV) matches lung perfusion with ventilation to optimize pulmonary gas exchange. However, it remains unclear whether acute HPV (occurring within seconds) and the vasoconstrictor response to sustained alveolar hypoxia (developing over several hours) are triggered by identical mechanisms. We investigated the effect of mitochondrial and NADPH oxidase inhibitors on both phases of HPV in intact rabbit lungs. These studies revealed that the sustained HPV is largely dependent on mitochondrial complex I and totally dependent on complex IV, whereas NADPH oxidase-dependence was only observed for acute HPV. These findings were reinforced by an alternative approach employing lungs from mice deficient in the NADPH oxidase subunit p47 phox . In these mice, which lack a subunit suggested to be important for the function of most NADPH oxidase isoforms, but not in gp91 phox deficient mice which represent only one isoform of NADPH oxidases, acute HPV was significantly reduced while non-hypoxia-induced vasoconstrictions elicited by the thromboxane mimetic U46619 were not affected. We concluded that the acute phase and the sustained phase of HPV are differentially regulated, with NADPH oxidase activity predominating in the acute phase, while a strong dependence on mitochondrial participation was observed for the second phase.
INTRODUCTION
Hypoxic pulmonary vasoconstriction (HPV) is an essential mechanism of the lung that matches perfusion to ventilation and thus helps to prevent arterial hypoxemia (for review, see 1;2 ) Despite the description of the relevance of this mechanism by von Euler and Liljestrand in 1946 3 , the underlying oxygen sensing and signal transduction processes have not been identified yet. Pathophysiological conditions such as adult respiratory distress syndrome (ARDS), severe pneumonia and liver cirrhosis may result in a lack of HPV with deterioration of pulmonary gas exchange. Alternatively, sustained generalized alveolar hypoxia, as it occurs in chronic obstructive and restrictive lung diseases, culminates in the development of pulmonary hypertension characterized by pronounced vascular remodeling.
We have recently demonstrated in isolated ventilated and perfused rabbit and mouse lungs that sustained hypoxic ventilation for at least 120 min results in a biphasic vasoconstrictor response and a loss of posthypoxic vasorelaxation, i.e. that the vasoconstrictor response after prolonged hypoxia did not return to baseline levels after re-oxygenation. This biphasic kinetics was characterized by an initial vasoconstrictor response peaking at 4-6 min, a pressure nadir at 15-20 min and a secondary progressive increase in PAP 4;5 . Against this background it remains to be clarified whether the acute HPV (occurring within seconds) and the sustained vasoconstrictor response (occurring during hypoxic ventilation of more than 20 min) are triggered by identical or different oxygen sensing and signal transduction pathways.
In a previous investigation we demonstrated that lung nitric oxide generation and reactive oxygen species contribute to the regulation of both the acute and sustained phase of HPV 4 .
The flavoprotein inhibitor diphenyleneiodonium (DPI), which inhibits both NADPH oxidases and mitochondria, suppressed the sustained phase of HPV with higher efficacy when compared to the acute phase of HPV. For both the acute and sustained phase of HPV there is ongoing discussion whether mitochondria, NADPH oxidases or alternative systems are the underlying oxygen sensors and whether they are regulated by identical or by different mechanisms 2;6-9 . Biphasic hypoxic vasoconstrictor responses have repeatedly been shown to occur in isolated vessels, but few studies have focused on the regulation in the intact organ [9] [10] [11] [12] [13] .
Therefore, we have employed two approaches to determine the possible differential contribution of mitochondria versus NADPH oxidases to the regulation of acute and sustained HPV in intact lungs. First, a pharmacological approach in isolated perfused and ventilated rabbit lungs targeting the different mitochondrial electron transport complexes as well as NADPH oxidases, and second, a genetic approach with mouse lungs deficient in the NADPH oxidase subunits gp91 phox and p47 phox , respectively. Essentially, we found that the mitochondrial respiratory chain complex I and, particularly, complex IV, have a much stronger impact on the regulation of the sustained phase of HPV in comparison to acute HPV, while the impact of nonphagocytic NADPH oxidase function was demonstrated only for the acute phase of HPV.
MATERIALS AND METHODS

Reagents
Rotenone, 1-methyl-4-phenylpyridinium iodide (MPP + ), 3-nitroproprionic acid (3-NPA),
antimycin A, and cyanide were from SIGMA-ALDRICH (Taufkirchen, Germany). The U46619 was from Paesel+Lorei (Franfurt am Main., Germany). The perfusate was purchased from SERAG-WIESSNER (Naila, Germany).
was from by CALBIOCHEM (Bad Soden, Germany). All other biochemicals were purchased from MERCK (Munich, Germany).
Animals
For rabbit lung investigations, Chinchilla bastard rabbits of either sex (2. mice (The Jackson Laboratory, Bar Harbor, USA) were used as controls. Mice weights ranged between 25 and 38 g, and weight-mached pairs of animals (wild-type and transgenic) were used to compensate for weight differences. Mice of either sex were used for the investigation with the same proportion of male and female mice in each group. No gender differences were observed concerning the vasoconstrictor response to hypoxia or the thromboxane mimetic U46619. All animal experiments were approved by the local governmental committee.
Rabbit and mouse lung isolation, perfusion and ventilation
The model of isolated perfused rabbit lungs has been described previously 4;15 . Briefly, the lungs were excised in deep anesthesia while being perfused with Krebs Henseleit buffer
mmol/L MgCl 2 and 275 mg glucose/100 ml); NaHCO 3 was adjusted to result in a constant pH of 7.37 -7.40. The total system volume was 250 ml, the buffer flow rate was 150 ml/min, and left atrial pressure was set at 1. (molecular weight 200,000) was employed. The total system volume was 13 ml. The flow rate was set at 2.0 ml/min.
Lungs included in the study were those that had a homogeneous white appearance with no signs of hemostasis, edema or atelectasis.
Hypoxic maneuvers
The technique of sequential and sustained hypoxic maneuvers in buffer-perfused mouse and rabbit lungs has been described previously 5;16;17 . Briefly, a gas mixing chamber (KM 60- 
U46619-induced vasocontrictions
To induce a hypoxia-independent vasoconstrictor response, mouse lungs were challenged with a bolus application of U46619 into the pulmonary artery as previously described, resulting in a final concentration of 4.5 nmol/L in the recirculating buffer fluid 5 . In these experiments two hypoxic ventilation maneuvers (10 min) alternating with 15 min periods of normoxic ventilation were performed, followed by the U46619 application. This protocol enabled a direct comparison of the vasoconstrictions to hypoxia and U46619 of each individual lung.
Sustained alveolar hypoxia in rabbit lungs
After an initial short-term period of hypoxia (10 min duration), which allows assessment of adequate lung response to this challenge 
Rotenone (mitochondrial complex I inhibitor)
40 nmol/L, followed by repetitive application of 40nmol/L every 25 min. Sustained alveolar hypoxia was started corresponding to the timing of the 3 rd hypoxic challenge. Due to the pharmacokinetics of rotenone sustained hypoxia was prolonged in these experiments to 135
min. The rotenone experiments were performed in the presence of L-NMMA (400µM) as this agent was shown to suppress HPV with higher specificity as compared to U46619-induced vasoconstrictions when lung NO synthesis was inhibited 19 .
3-NPA (mitochondrial complex II inhibitor)
0.6 mmol/L (application 15 min prior to onset of hypoxia), followed by supplementation of 150 ml of the perfusate with fresh buffer 75 min later. Sustained alveolar hypoxia was started corresponding to the timing of the 4 th hypoxic challenge. 
Antimycin A (mitochondrial complex III inhibitor)
Cyanide (mitochondrial complex IV inhibitor)
Continuous infusion of 50 µmol/L/h for 15 min, followed by an infusion of 30 µmol/L/h.
Sustained alveolar hypoxia was started corresponding to the timing of the 3 th hypoxic challenge.
4-(2-Aminoethyl)benzenesulfonyl fluoride (AEBSF, NADPH oxidase inhibitor))
500 µmol/L, followed by continuous infusion for 215 min of a dosage resulting in an increase of 100µmol/L/h. Thereafter infusion rate was decreased to 50 µmol/L/h. Sustained alveolar hypoxia was started corresponding to the timing of the 5 th hypoxic challenge. The AEBSF experiments were performed in the presence of L-NMMA (400µmol/L) to make them comparable to those from our previous investigation with the application of the NADPH oxidase inhibitor diphenyleneiodonium in the presence of NO synthase inhibition 4;19 . DPI is known to also block lung NO synthesis and thus NO synthase has to be blocked to avoid interference with this vasodilatory agent.
Sustained alveolar hypoxia in mouse lungs
After an initial 10 min period of hypoxic ventilation (1 % O 2 ) followed by a 15 min period of normoxic ventilation a 180 min period with hypoxic ventilation (1 % O 2 ) was started.
Measurement of intravascular superoxide release by electronspinresonance (ESR) spectroscopy
Intravascular superoxide release was determined as described previously in detail 20 . 
RESULTS
Pharmacological interventions targeting mitochondrial complexes I-IV
Hypoxic ventilation of isolated rabbit lungs for 120 min with 3 % O 2 resulted in a biphasic vasoconstrictor response with a first maximum occurring within ~6 min, a pressure nadir at ~16 min and a second, sustained rise in PAP ( fig. 1 ).
When applying the mitochondrial complex I inhibitor MPP + in a mode that reduced acute A prerequisite for the application of cyanide was to prove whether it specifically affects acute HPV in comparison to non-hypoxia-induced vasoconstriction as this, in contrast to the other inhibitors applied, has not previously been described. In fact, 25 µM cyanide suppressed acute HPV to 37.8 ± 4.5 % of the control response, whereas the vasoconstrictor response to the thromboxane mimetic U46619 was not significantly reduced at this dose of cyanide. Cyanide (80 µM) totally suppressed acute HPV but reduced U46619-induced vasoconstriction only to 65.5 ± 8.0% of the initial response.
Pharmocological interventions targeting NADPH oxidases
Application of the NADPH oxidase inhibitor AEBSF in a mode that inhibited acute HPV by approximately 70 % resulted in only a minor effect on sustained HPV (fig 6) .
Acute hypoxic vasoconstriction in mice deficient for NADPH oxidase subunits
When comparing the acute hypoxic vasoconstrictor response to a 10 min hypoxic ventilation period (1 % O 2 ) in mice deficient for the NADPH oxidase subunits gp91 phox and p47 phox , HPV was significantly lower in p47 phox -deficient mice ( fig. 7a ). This reduction was specific for the hypoxic vasoconstrictor response, since vasoconstrictions induced by the thromboxane mimetic U46619 were not significantly reduced in these mice ( fig. 7b) 
Superoxide release in acute hypoxia
Quantification of intravascular superoxide release in wild-type mice during normoxic and acute hypoxic ventilation by ESR spectroscopy revealed a decreased superoxide release during hypoxic ventilation (Fig. 9) . In p47 phox -deficient mice no significant superoxide release was noted during normoxic ventilation. In contrast, acute hypoxic ventilation provoked an increased superoxide release in p47 phox -deficient mice when compared to normoxia (Fig. 9 ).
DISCUSSION
The new findings of the present investigation are first) that the acute and sustained phase of the biphasic course of hypoxic vasoconstriction differ with respect to mitochondria-and NADPH-oxidase-dependency, second) that mitochondrial complex IV in particular has a tremendous and mitochondrial complex I has a strong impact on the sustained phase of HPV compared to acute HPV, third) that by investigating two different NADPH oxidase-deficient mouse strains, we provide concrete evidence for the involvement of non-phagocytic NADPH oxidases in the regulation of HPV, fourth) that such involvement is observed for the acute, but not for the sustained phase of HPV, and fifth) that a non-phagocytic NADPH oxidase may be activated rather than inhibited in acute hypoxia, as normoxic vascular tone was not elevated in p47 phox -deficient mice.
General features of the biphasic vasoconstrictor response in isolated lungs.
The biphasic kinetics of HPV to an ongoing hypoxic challenge was frequently reported for isolated pulmonary arteries but has less frequently been investigated in intact animals, in in vivo perfused or ex vivo perfused lungs 6;9;10;21-23 . We recently described that in isolated perfused and ventilated rabbit lungs a sustained hypoxic ventilation period of 120 -180 min provoked a biphasic vasoconstrictor response with an early maximum occurring within 6 min, followed by a pressure nadir and a second, sustained vasoconstrictor phase 4 . Moreover, when investigating isolated buffer-perfused mouse lungs totally explanted from the body, we recently showed that the same kinetics as demonstrated for the rabbit lung are also found in lungs from C57BL/6N mice 5 .
There is ongoing discussion as to the nature of the oxygen sensor mechanism of HPV, and 
Pharmacological interventions in the isolated rabbit lung
In a pharmacological approach we investigated whether inhibitors of the mitochondrial electron transport complexes I to IV have different effects on the acute and the sustained phase of HPV. All of these inhibitors were shown in previous investigations from our laboratory, or in the present study, to specifically inhibit acute HPV when compared with their effect on non-hypoxia-induced vasoconstrictions in response to the thromboxane mimetic U46619 17;18 . The only exception was 3-NPA, that was previously characterized as an unspecific inhibitor of acute HPV when compared to U46619-induced vasoconstriction 18 .
However, we are not aware of any complex II inhibitor that specifically inhibits acute HPV in the rabbit lung. While the complex II inhibitor suppressed both phases of HPV to the same degree, the complex I inhibitors strongly suppressed the sustained phase of HPV with only a minor effect on acute HPV in the dosage applied. In contrast, the complex III inhibitor antimycin A inhibited both phases of HPV to a similar extent. Leach et al recently demonstrated that the complex I inhibitor rotenone as well as the complex III inhibitor myxothiazole suppressed both phases of HPV in isolated pulmonary arteries 6 . However, no conclusion could be drawn from their experiments on a possible different impact of these agents on the different phases of HPV as they applied a dosage that fully suppressed both acute and sustained HPV. The fact that acute HPV is inhibitable by proximal electron transport chain inhibitors is in line with the investigation of Waypa et al. 28 who found that rotenone and myxothiazol inhibited acute HPV. However, this investigation did not focus on the effect of those inhibitors on sustained HPV.
The most prominent effect in our study was observed with cyanide that fully blocked sustained HPV at a dosage that only slightly reduced acute HPV. This effect was much more prominent than that observed in isolated rat pulmonary arterial vessels 6 . Moreover, we demonstrated that the lungs still responded to an acute hypoxic challenge after sustained hypoxia in the presence of cyanide, proving that it was not a lack of energy that is responsible for this effect. This selective effect of cyanide on sustained HPV is in line with the observation of Waypa et al. in isolated rat lungs that acute HPV was not affected by cyanide 28 . Going beyond these studies with sole investigation of acute HPV, Wiener and Sylvester investigated in detail the vasodilation and sustained HPV following acute HPV in isolated ferret lungs. In these studies high glucose levels prevented the vasodilation following acute HPV 9;13 whereas pyruvate did not 9 . This suggests that the prevention of the vasodilation by glucose was not dependent on glucose metabolism downstream of pyruvate. However, low glucose concentrations inhibited sustained HPV, an effect that was prevented by pyruvate 9 .
These data suggest that glucose metabolism beyond pyruvate, i. e. a decreased oxidative phosphorylation or an altered mitochondrial ROS production is responsible for the inhibition of sustained HPV. This explanation is well in line with our study, as all inhibitors of the mitochondrial electron transport chain are suggested to result in a reduced oxidative phosphorylation in the concentrations applied 29;30;31;32;33;34 . In accordance with the observations of Wiener and Sylvester 9;13 low glucose also suppressed sustained HPV in isolated rat intrapulmonary arteries 6 . However, in this investigation pyruvate did not reverse suppression of sustained HPV, suggesting that glucose facilitated sustained HPV by a mechanism independent from glucose metabolism downstream of pyruvate. This discrepancy may be explained by the fact that the pyruvate concentration applied was much lower than that used by Wiener and Sylvester 9 .
As indicated above, alternatively to ATP production, the effects of the mitochondrial inhibitors may be related to mitochondrial ROS production as previously suggested for acute Concerning the ongoing discussion as to whether mitochondria or NAD(P)H oxidases may play a fundamental role in pulmonary oxygen sensing, we and others previously demonstrated that the NAD(P)H oxidase inhibitors DPI and AEBSF specifically suppressed acute HPV 19;36 .
Moreover, investigating the effect of DPI on the acute and sustained phase of HPV we recently demonstrated that DPI more prominently suppressed sustained HPV 4 . As this inhibitor also blocks, for example, complex I of the mitochondrial electron transport chain we, in the present study, investigated the effect of the second structurally unrelated NADPH oxidase inhibitor AEBSF. Interestingly, this agent only affected the acute phase of HPV.
These observations, together with the inhibitory effects of the complex I inhibitors rotenone and MPP + , are in line with the interpretation that the effect of DPI observed on the sustained phase of HPV may be related to its inhibitory effect on mitochondrial electron transport complex I.
Investigations in isolated perfused lungs of NADPH oxidase-deficient mice
Concerning the NADPH oxidase hypothesis in the context of HPV, the lack of specificity of NADPH oxidase inhibitors is thought to cause the different opinions between different investigators 2;8 . Thus, we investigated the impact of a deficiency in two different NADPH oxidase subunits (gp91 phox and p47 phox ) in an isolated mouse lung preparation on acute HPV.
The unaltered response to acute HPV in gp91 phox -deficient mice is in line with a previous observation, demonstrating that acute HPV is not critically dependent on the NADPH oxidase subunit gp91 phox,37 . However, the NADPH oxidase is a multiprotein complex consisting of the membrane bound subunits gp91 phox , p22 and the cytosolic subunits p40 phox , p47 phox and p67 phox . Moreover, isoforms of gp91 phox as well as of p47 phox and p67 phox have recently been identified and have been shown to play a role as "low-output" NADPH oxidases for physiological and pathophysiological processes 38 . When comparing acute HPV in mice deficient for p47 phox with wild-type mice, HPV was attenuated. This attenuation was specific for HPV since vasconstrictions induced by the thromboxane mimetic U46619 were not reduced when compared with wild-type controls. The fact that baseline normoxic vascular tone was not enhanced in p47 phox -deficient mice compared to wild-type mice demonstrates that reduction in the strength of HPV in these mice is not induced by some mimicking of hypoxia due to the lack of p47 phox . Thus, these findings in genetically engineered mice support the concept that an NADPH oxidase derived increase in reactive oxygen species release is involved in triggering acute HPV. Our data from the quantification of lung superoxide release are in line with this suggestion. Whereas total normoxic superoxide release was decreased in wild-type mice during acute hypoxia, p47 phox -deficient mice released an enhanced amount of superoxide during hypoxic ventilation. In contrast to wild-type mice no significant superoxide release was noted during normoxic ventilation in p47 phox -deficient mice. Speculatively, the hypoxia-induced increase in lung superoxide release triggers HPV and is hidden behind the overall decrease in lung superoxide release observed in wild-type mice. If this concept is right, the attenuated HPV in p47 phox-/-mice may be related to some loss of this increase. Consequently the HPV-specific increase in superoxide release should be higher in wild-type mice than in p47-deficient mice, but is not seen due to the overall decrease in superoxide release in wild-type mice. This interpretation is supported by the fact that baseline PAP was not higher in 47 phox-/-mice compared to wild-type mice, as would have been the case if a decreased superoxide release triggers HPV.
The fact that p47 phox -but not gp91 phox -deficient mice showed a reduced acute HPV point to a non-phagocytic NADPH oxidase playing an important role for regulation of acute HPV. In conclusion, we demonstrated in intact lungs that the acute and the sustained phase of HPV are differentially regulated. While mitochondria-dependent pathways, especially those linked to complex I and IV, have a stronger effect on the regulation of sustained HPV, NADPH oxidase-dependent pathways seem to be solely linked to the regulation of acute HPV.
Moreover, our investigation provided evidence from a non-pharmacological approach that the regulation of acute HPV is dependent on nonphagocytic NADPH oxidases. The fact that p47 phox -deficient mice have no elevated vascular tone, support the conclusion that a nonphagocytic NADPH oxidase is activated in acute hypoxia. Fig. 1 Pulmonary artery pressure response during sustained hypoxic ventilation (3 % O 2 ) for 120 min.
FIGURE LEGENDS
Baseline pulmonary arterial pressure at time point zero was 5.5 ± 0.3 (n = 10). Data are means ± SEM of n= 5 for both groups. A bar indicates significant differences between the hypoxic and the normoxic group.
∆PAP: Change in pulmonary arterial pressure as referenced to the starting point of hypoxic ventilation (time set at zero). Normoxia controls were treated in the same way as hypoxia controls but without hypoxic ventilation. Bar indicates significant differences between cyanide treated lungs and the hypoxia control. Changes in pulmonary artery pressure from baseline, referenced at time zero, are given (∆PAP; means ± SEM; at least n = 5 each). Data are for lungs undergoing sustained hypoxia, as well as for normoxically-ventilated lungs. Bar indicates significant differences between p47 phox-/-mice and wild-type mice in response to hypoxia. 
